title: Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.
abstract: In the present study, we investigated the effectiveness of liposomes coated with a neoglycolipid consisting of mannotriose and dipalmitoylphosphatidylcholine (Man3-DPPE) as an adjuvant for induction of mucosal immunity. Immunization of BALB/c mice with ovalbumin (OVA)-encapsulated Man3-DPPE-coated liposomes (oligomannose-coated liposomes; OMLs) by a nasal route produced high levels of OVA-specific IgG and IgA antibodies in serum of immunized mice 1 week after the last nasal immunization, whereas no significant serum antibody responses were observed in mice that received OVA in uncoated liposomes or OVA alone. Seven weeks after the last nasal immunization, nasal challenge with an excess amount of OVA in mice that had received OVA/OMLs led to an anamnestic response to the antigen that resulted in 5- to 10-fold increases of antigen-specific serum IgG and IgA antibodies. Only mice immunized nasally with OML/OVA secreted antigen-specific secretory IgA in nasal washes and produced interferon-gamma secreting cells in nasopharyngeal-associated lymphoreticular tissue. Taken together, these results show that nasal administration of OMLs induces mucosal and systemic immunity that are specific for the entrapped antigen in the liposomes. Thus, liposomes coated with synthetic neoglycolipids might be useful as adjuvants for induction of mucosal immunity.
authors.affiliation: Institute of Glycoscience and Department of Applied Biochemistry, Tokai University, Hiratsuka, Kanagawa, 259-1292, Japan.
authors.forename: Mariko
authors.initials: M
authors.lastname: Ishii
authors.forename: Naoya
authors.initials: N
authors.lastname: Kojima
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000281:Administration, Intranasal; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002772:Cholera Toxin / Q000276:immunology; D016207:Cytokines / Q000096:biosynthesis / Q000378:metabolism; D003713:Dendritic Cells / Q000187:drug effects / Q000378:metabolism; D000939:Epitopes / Q000187:drug effects; D007114:Immunization; D007070:Immunoglobulin A / Q000097:blood; D008081:Liposomes / Q000008:administration & dosage / Q000494:pharmacology*; D008358:Mannose / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D017817:Nasal Lavage Fluid / Q000276:immunology; D009297:Nasal Mucosa / Q000187:drug effects / Q000276:immunology*; D010047:Ovalbumin / Q000276:immunology; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D014312:Trisaccharides / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology*
chemical_list: D000276:Adjuvants, Immunologic; D016207:Cytokines; D000939:Epitopes; D007070:Immunoglobulin A; D008081:Liposomes; D014312:Trisaccharides; C023872:mannotriose; D010047:Ovalbumin; D002772:Cholera Toxin; D008358:Mannose